TCA
CME icon

Transcend Capital Advisors’s CME Group CME Stock Holding History

Transcend Capital Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Buy
3,350
+24
+0.7% +$6.64K 0.05% 344
2026
Q1 		$982K Buy
3,326
+311
+10% +$92.4K 0.08% 233
2025
Q4 		$823K Sell
3,015
-40
-1% -$10.9K 0.06% 262
2025
Q3 		$825K Buy
3,055
+36
+1% +$9.79K 0.06% 284
2025
Q2 		$832K Sell
3,019
-304
-9% -$82.7K 0.06% 258
2025
Q1 		$881K Buy
3,323
+19
+0.6% +$4.69K 0.06% 271
2024
Q4 		$767K Sell
3,304
-556
-14% -$128K 0.06% 275
2024
Q3 		$852K Sell
3,860
-378
-9% -$78.2K 0.06% 291
2024
Q2 		$833K Buy
4,238
+106
+3% +$21.9K 0.06% 279
2024
Q1 		$889K Buy
4,132
+1,137
+38% +$239K 0.07% 247
2023
Q4 		$631K Buy
2,995
+50
+2% +$10.7K 0.06% 276
2023
Q3 		$590K Sell
2,945
-359
-11% -$71.4K 0.06% 269
2023
Q2 		$612K Sell
3,304
-211
-6% -$39K 0.06% 272
2023
Q1 		$673K Sell
3,515
-545
-13% -$98.6K 0.07% 250
2022
Q4 		$683K Sell
4,060
-172
-4% -$29.9K 0.07% 242
2022
Q3 		$750K Buy
4,232
+167
+4% +$33K 0.08% 227
2022
Q2 		$832K Buy
4,065
+360
+10% +$76.3K 0.09% 225
2022
Q1 		$881K Buy
3,705
+8
+0.2% +$1.88K 0.08% 233
2021
Q4 		$845K Sell
3,697
-224
-6% -$49.3K 0.07% 232
2021
Q3 		$860K Buy
3,921
+4
+0.1% +$810 0.08% 229
2021
Q2 		$831K Buy
3,917
+5
+0.1% +$1.06K 0.12% 170
2021
Q1 		$795K Sell
3,912
-401
-9% -$79K 0.1% 207
2020
Q4 		$785K Buy
4,313
+574
+15% +$97.6K 0.1% 194
2020
Q3 		$626K Buy
+3,739
New +$630K 0.11% 159
2020
Q2 		– Sell
-4,265
Closed -$737K – 133
2020
Q1 		$737K Buy
4,265
+157
+4% +$31.2K 0.22% 113
2019
Q4 		$825K Buy
+4,108
New +$843K 0.22% 109

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Transcend Capital Advisors's CME Position: Q2 2026 in Review

Transcend Capital Advisors increased its CME Group (CME) stake by 0.72% in Q2 2026, buying an estimated $6.64K and bringing the position to 3,350 shares worth $740K. The position accounts for 0.05% of the portfolio, ranked #344.

Transcend Capital Advisors first reported a position in CME in Q4 2019 and has held it in 26 quarters since. The position peaked at $982K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Transcend Capital Advisors held 3,350 shares of CME Group worth $740K as of Q2 2026.
  • Transcend Capital Advisors bought 24 CME Group shares in Q2 2026, an estimated $6.64K.
  • CME Group made up 0.05% of Transcend Capital Advisors's portfolio in Q2 2026, its #344 holding.
  • Transcend Capital Advisors first reported a position in CME Group in Q4 2019 and has held it in 26 quarters since.
  • Transcend Capital Advisors's CME Group position peaked at $982K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.